| PERIOD ENDING | 31-Dec-08 | 31-Dec-07 | 31-Dec-06 | | Total Revenue | 135,152,168 | 146,404,787 | 200,142,957 | | Cost of Revenue | 104,760,446 | 111,062,552 | 165,926,062 | | | Gross Profit | 30,391,722 | 35,342,236 | 34,216,895 | | | Operating Expenses | | Research Development | 4,306,634 | 4,651,418 | 7,038,519 | | Selling General and Administrative | 19,362,230 | 19,116,769 | 24,442,714 | | Non Recurring | (1,673,314) | (39,768) |
-
| | Others |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | 8,396,173 | 11,613,817 | 2,735,662 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (3,496,056) | 3,828,067 | 2,866,371 | | Earnings Before Interest And Taxes | 4,900,117 | 15,441,884 | 5,602,033 | | Interest Expense | 960,006 | 1,919,189 | 330,075 | | Income Before Tax | 3,940,112 | 13,522,695 | 5,271,958 | | Income Tax Expense | 1,537,983 | 6,371,765 | 932,132 | | Minority Interest |
-
|
-
| (73,937) | | | | Net Income From Continuing Ops | 2,402,129 | 7,150,930 | 4,265,889 | | | Non-recurring Events | | Discontinued Operations | (408,813) | (1,281,423) |
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
| (5,281) | | Other Items |
-
|
-
|
-
| | | | Net Income | 1,993,316 | 5,869,507 | 4,260,608 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $1,993,316 | $5,869,507 | $4,260,608 |
|
0.02% Nasdaq 
0.33%
Income Statement
